fluoxetine has been researched along with bupropion in 112 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (3.57) | 18.7374 |
| 1990's | 26 (23.21) | 18.2507 |
| 2000's | 38 (33.93) | 29.6817 |
| 2010's | 34 (30.36) | 24.3611 |
| 2020's | 10 (8.93) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Cohen, LJ; Grothe, DR | 1 |
| Brickman, A; Goodnick, PJ; Klimas, NG; Sandoval, R | 1 |
| Novac, A | 1 |
| Salzman, C | 1 |
| George, MS; Lydiard, RB | 1 |
| Ascher, JA; Batey, SR; Feighner, JP; Gardner, EA; Johnston, JA; Khayrallah, MA; Lineberry, CG | 1 |
| Settle, EC | 1 |
| Nierenberg, AA | 1 |
| Fernandez, F; Levy, JK | 1 |
| Ostrow, D | 1 |
| Dahms, JL; Seiden, LS; Shaughnessy, RA | 1 |
| Gershon, S; Kelwala, S; Stanley, M | 1 |
| Feighner, JP | 1 |
| Preskorn, SH | 1 |
| Fasiczka, AL; Frank, E; Jennings, JR; Kupfer, DJ; Nofzinger, EA; Reynolds, CF; Sullivan, LR; Thase, ME | 1 |
| Cohen, BM; Goldstein, E; Kolbrener, M; Lucier, J; Mayer, PV; Stoll, AL; Suplit, B; Tohen, M | 1 |
| Labbate, LA; Pollack, MH | 1 |
| Adler, LA; Nierenberg, AA; Peselow, E; Rosenthal, M; Zornberg, G | 1 |
| Batey, SR; Cole, JO; Gardner, EA; Hughes, AR; Johnston, JA; Lineberry, CG; Walker, PW | 1 |
| Short, DD; Workman, EA | 1 |
| Young, SJ | 1 |
| DePalma, RL; Katholi, CR; Modell, JD; Modell, JG | 1 |
| Baldessarini, RJ; Bodkin, JA; Gardner, DM; Lasser, RA; Wines, JD | 1 |
| Brown, WA; Lund, SA; Pearlstein, TB; Scheft, H; Stone, AB; Zlotnick, C | 1 |
| Grimes, JB; Hines, A; Labbate, LA; Pollack, MH | 1 |
| Lucki, I; Rénéric, JP | 1 |
| Thase, ME | 1 |
| Nelson, JC | 1 |
| Dogin, JW; Findling, RL | 1 |
| Castaneda, R; Hardy, M; Levy, R; Trujillo, M | 1 |
| Berman, SR; Fasiczka, AL; Frank, E; Friedman, ES; Nofzinger, EA; Reynolds, CF; Thase, ME | 1 |
| Court, MH; Duan, SX; Greenblatt, DJ; Hesse, LM; Shader, RI; Venkatakrishnan, K; von Moltke, LL | 1 |
| Ferguson, JM | 1 |
| Ascher, J; Batey, S; Bolden-Watson, C; Book, MJ; Coleman, CC; Jamerson, B; King, BR; Metz, A; Richard, N; Segraves, RT | 1 |
| Kelley, AE; Sasaki-Adams, DM | 1 |
| Li, SX; Perry, KW; Wong, DT | 1 |
| Baker, GB; Kennedy, SH; Masellis, M; McCann, SM; McIntyre, RS; McKay, G; Raskin, J | 1 |
| Chrousos, GP; Gabry, KE; Gold, PW; McCann, SM; Mostafa, RM; Negrao, AB; Rice, KC; Sternberg, E; Webster, EL | 1 |
| Atkinson, T | 1 |
| Arban, R; Bettelini, L; Corsi, M; Gerrard, PA; Griffante, C; Marchi, M; Varnier, G; Zanetti, L; Zocchi, A | 1 |
| Fava, M; Mahal, Y; McGrath, P; Papakostas, GI; Petersen, T; Quitkin, F; Stewart, J | 1 |
| Andreatini, R; Chollet, CA | 1 |
| Jaffe, R; Leavitt, R; Wind, T | 1 |
| Li, Z; Maggard, M; Maglione, M; Mojica, WA; Morton, SC; Shekelle, PG; Shugarman, L; Solomon, V; Suttorp, M; Tu, W | 1 |
| Blackburn-Munro, G; Nielsen, AN; Pedersen, LH | 1 |
| Folk, JE; Rice, KC; Torregrossa, MM; Watson, SJ; Woods, JH | 1 |
| Csoka, AB; Shipko, S | 1 |
| Billes, SK; Cowley, MA | 2 |
| Breza, TS; Magro, CM; Porcu, P; Zheng, P | 1 |
| Amara, SG; Mortensen, OV | 1 |
| Chan, CH; Huang, MC; Liu, HC | 1 |
| Dobkin, RD; Marin, H; Menza, MA | 1 |
| Aiso, S; Ito, M; Katada, M; Kawasaki, A; Matsuoka, M; Nishizawa, K; Terashita, K; Torii, K | 1 |
| Rosenzweig-Lipson, S; Schechter, LE; Sukoff Rizzo, SJ | 1 |
| Brang, D; Ramachandran, VS | 1 |
| Al-Zaman, Y; Aylwin, S | 1 |
| Harvey, I; Lilford, R; Song, F | 1 |
| Alcantara, LF; Bolaños-Guzmán, CA; Iñiguez, SD; Maffeo, ML; Manojlovic, Z; Parise, EM; Schuh, B; Warren, BL | 1 |
| Billups, SJ; Delate, T; Dugan, D | 1 |
| Burnand, B; Nanchen, D; Peytremann-Bridevaux, I; Walther, MR; Willi, C | 1 |
| Applebee, GA; Attarian, HP; Schenck, CH | 1 |
| Bergeron, R; Blier, P; Hébert, C; Laberge, L; Tremblay, P; Ward, HE | 1 |
| Desmarais, JE; Looper, KJ | 1 |
| Rush, AJ | 1 |
| Jesse, CR; Nogueira, CW; Wilhelm, EA | 1 |
| Bartell, SE; Furlong, ET; Logue, A; Painter, MM; Schoenfuss, HL; Schultz, MM; Werner, SL | 1 |
| Costentin, J; Do Rego, JC; Müller, LG; Nunes, JM; Rates, SM; Stein, AC; Stolz, ED; Viana, AF; von Poser, GL | 1 |
| Humpston, CS; Robinson, ES; Wood, CM | 1 |
| Fernández-Guasti, A; Ventura-Aquino, E | 1 |
| Cadeddu, R; Carboni, E; Ibba, M; Sadile, A | 1 |
| Kearney, T; Wu, AH | 1 |
| Chen, CC; Cheng, KH; Hung, CH; Kuo, CH; Tsai, JH; Wang, PW; Yang, P | 1 |
| Leal, RB; Lopes, MW; Manosso, LM; Moretti, M; Neis, VB; Rodrigues, AL | 1 |
| Filipek, B; Olczyk, A; Pytka, K; Rapacz, A; Sapa, J; Waszkielewicz, A; Zygmunt, M | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N | 1 |
| Collins, SL; Contreras-Mora, HM; Correa, M; Errante, EL; Rowland, MA; Salamone, JD; Yohn, SE | 1 |
| Rahman, S; Roni, MA | 1 |
| Domingues, K; Lino de Oliveira, C; Suman, PR; Theindl, LC; Zerbinatti, N | 1 |
| Lin, CM; Little, K; Reynolds, PM | 1 |
| Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A | 1 |
| Cardozo, T; Felsovalyi, K; Grunebaum, MF; Kim, EJ; Shmelkov, SV; Young, LM | 1 |
| Camsari, DD; Croarkin, PE; Daskalakis, ZJ; Gresbrink, MA; Lewis, CP; Nandakumar, AL; Sonmez, AI | 1 |
| Hong, Y; Joo, YH; Lee, JS; Shon, SH; Yoon, W | 1 |
| Alexander, KS; Miller, LL; Patton, TB; Rodriguez, TR; Sarfo, AN | 1 |
| Alen, F; Antón, M; Arco, R; Ballesta, A; de Fonseca, FR; de Heras, RG; Nogueira-Arjona, R; Orio, L; Pavón, FJ; Ramírez-López, M; Romero-Sanchiz, P; Serrano, A; Suárez, J; Vargas, A | 1 |
| Ishibashi, T; Iwadate, R; Kawai, H; Kawashima, Y; Kudo, N; Mitsumoto, A | 1 |
| Anagnostaras, SG; Carmack, SA; Hammam, L; Pantoni, MM | 1 |
| Chen, C; Shan, W | 1 |
| Andrade, CH; Barbosa-Filho, JM; Capibaribe, VC; Carvalho, AMR; Chaves Filho, AJM; Chaves, RC; Fonteles, MMF; Gutierrez, SJC; Macedo, DS; Mallman, ASV; Mottin, M; Oliveira, ICM; Oliveira, NF; Rebouças, MO; Sartori, DP; Silva, DMA; Sousa, FCF; Valentim, JT | 1 |
| Abelaira, HM; Borba, LA; Botelho, MEM; de Moura, AB; Fileti, ME; Garbossa, L; Goldim, MP; Gonçalves, CL; Ignácio, ZM; Petronilho, F; Quevedo, J; Réus, GZ; Rosa, T; Veron, DC | 1 |
| McDonald, MD; Sebastiani, J | 1 |
| Haas, DM; Marks, C; Quinney, SK; Silvola, R; Teal, E | 1 |
| Camino, S; Godoy, A; Smith, J; Strejilevich, SA; Szmulewicz, A | 1 |
| Gedde-Dahl, A; Molden, E; Spigset, O | 1 |
| Carratalá-Ros, C; Correa, M; Martínez-Verdú, A; Olivares-García, R; Salamone, JD | 1 |
| Chen, L; Fan, H; Hu, Q; Li, K; Liu, X; Shi, Y; Wu, K; Zhong, J; Zhou, J | 1 |
| Gomes, ALA; Herrmann, AP; Pilger, DA; Rates, SMK; Rojas, CS; Speck, ML; Willig, JB | 1 |
19 review(s) available for fluoxetine and bupropion
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Major depression: its recognition and treatment. Part 2. Second-generation and newer antidepressants.
Topics: Antidepressive Agents; Bupropion; Clomipramine; Depression; Female; Fluoxetine; Humans; Male; Maprotiline; Selective Serotonin Reuptake Inhibitors; Trazodone | 1992 |
Monoamine oxidase inhibitors and atypical antidepressants.
Topics: Aged; Antidepressive Agents; Bupropion; Depressive Disorder; Fluoxetine; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales; Trazodone | 1992 |
Speed of onset of action of the newer antidepressants--fluoxetine and bupropion.
Topics: Antidepressive Agents; Bupropion; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Meta-Analysis as Topic; Psychiatric Status Rating Scales | 1991 |
Psychopharmacotherapy of psychiatric syndromes in asymptomatic and symptomatic HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antidepressive Agents; Anxiety Disorders; Bupropion; Depressive Disorder; Female; Fluoxetine; HIV Infections; Humans; Male; Mental Disorders; Neurocognitive Disorders; Psychotic Disorders | 1991 |
History of antidepressants: successes and failures.
Topics: Albuterol; Animals; Antidepressive Agents; Brompheniramine; Bupropion; Clinical Trials as Topic; Depressive Disorder; Dibenzocycloheptenes; Drug Evaluation, Preclinical; Fluoxetine; History, 20th Century; Humans; Monoamine Oxidase Inhibitors; Propiophenones; Psychopharmacology; Receptors, Adrenergic; Receptors, Serotonin; Trazodone; Zimeldine | 1983 |
The new generation of antidepressants.
Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Brompheniramine; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Monoamine Oxidase Inhibitors; Propiophenones; Zimeldine | 1983 |
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
Atypical antidepressants versus imipramine in the treatment of major depression: a meta-analysis.
Topics: Antidepressive Agents; Bupropion; Depressive Disorder; Fluoxetine; Humans; Imipramine; Trazodone | 1993 |
Depression, sleep, and antidepressants.
Topics: Adult; Antidepressive Agents; Bupropion; Circadian Rhythm; Comorbidity; Depressive Disorder; Electroencephalography; Female; Fluoxetine; Humans; Male; Polysomnography; Sleep; Sleep Wake Disorders; Sleep, REM; Terminology as Topic | 1998 |
Augmentation strategies with serotonergic-noradrenergic combinations.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bupropion; Clinical Trials as Topic; Depressive Disorder; Desipramine; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1998 |
Psychopharmacology of ADHD: children and adolescents.
Topics: Adolescent; Age Factors; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Cyclohexanols; Dextroamphetamine; Drug Administration Schedule; Fluoxetine; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Pemoline; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
The effects of antidepressants on sexual functioning in depressed patients: a review.
Topics: Adult; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Sexuality; Single-Blind Method; Triazoles | 2001 |
Pharmacological and surgical treatment of obesity.
Topics: Adult; Appetite Depressants; Bupropion; Cyclobutanes; Diethylpropion; Fluoxetine; Fructose; Gastric Bypass; Gastroplasty; Humans; Lactones; Lipase; Obesity; Orlistat; Phentermine; Topiramate | 2004 |
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide | 2008 |
Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bias; Bupropion; Data Interpretation, Statistical; Drug Therapy; Fluoxetine; Haloperidol; Humans; Imipramine; Meta-Analysis as Topic; Nicotine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Smoking Cessation; Treatment Outcome | 2008 |
Interactions between tamoxifen and antidepressants via cytochrome P450 2D6.
Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Venlafaxine Hydrochloride | 2009 |
Pharmacological and non-pharmacological treatments for major depressive disorder in adults: A systematic review and network meta-analysis.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Cognitive Behavioral Therapy; Depressive Disorder, Major; Fluoxetine; Humans; Mirtazapine; Network Meta-Analysis; Treatment Outcome; Venlafaxine Hydrochloride; Vortioxetine | 2019 |
Are all antidepressants the same? The consumer has a point.
Topics: Antidepressive Agents; Bupropion; Citalopram; Fluoxetine; Humans; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2023 |
13 trial(s) available for fluoxetine and bupropion
| Article | Year |
|---|---|
Speed of onset of action of the newer antidepressants--fluoxetine and bupropion.
Topics: Antidepressive Agents; Bupropion; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Meta-Analysis as Topic; Psychiatric Status Rating Scales | 1991 |
Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Body Weight; Bupropion; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Patient Dropouts; Personality Inventory; Placebos; Propiophenones; Psychiatric Status Rating Scales | 1991 |
The new generation antidepressants: promising innovations or disappointments?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dopamine; Drug Evaluation; Fluoxetine; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Receptors, Neurotransmitter; Serotonin; Trazodone; Zimeldine | 1985 |
History of antidepressants: successes and failures.
Topics: Albuterol; Animals; Antidepressive Agents; Brompheniramine; Bupropion; Clinical Trials as Topic; Depressive Disorder; Dibenzocycloheptenes; Drug Evaluation, Preclinical; Fluoxetine; History, 20th Century; Humans; Monoamine Oxidase Inhibitors; Propiophenones; Psychopharmacology; Receptors, Adrenergic; Receptors, Serotonin; Trazodone; Zimeldine | 1983 |
The new generation of antidepressants.
Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Brompheniramine; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Monoamine Oxidase Inhibitors; Propiophenones; Zimeldine | 1983 |
REM sleep enhancement by bupropion in depressed men.
Topics: Adult; Age Factors; Bupropion; Cognitive Behavioral Therapy; Depressive Disorder; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep, REM | 1995 |
Trazodone for antidepressant-associated insomnia.
Topics: Adult; Bupropion; Confidence Intervals; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Male; Placebos; Sleep; Sleep Initiation and Maintenance Disorders; Trazodone | 1994 |
Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Female; Fluoxetine; Humans; Middle Aged; Premenstrual Syndrome; Psychiatric Status Rating Scales | 1997 |
A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Multicenter Studies as Topic; Patient Compliance; Patient Satisfaction; Sexual Dysfunction, Physiological | 2001 |
Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Cytochrome P-450 CYP2D6; Dopamine Uptake Inhibitors; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Switching to bupropion in fluoxetine-resistant major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder, Major; Drug Resistance; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2003 |
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Bupropion; Dizziness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Pilot Projects; Piperazines; Quality of Life; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2007 |
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
Topics: Adult; Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Psychometrics; Secondary Prevention; Venlafaxine Hydrochloride | 2010 |
83 other study(ies) available for fluoxetine and bupropion
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome.
Topics: Adult; Bupropion; Depressive Disorder; Fatigue Syndrome, Chronic; Female; Fluoxetine; Follow-Up Studies; Homovanillic Acid; Humans; Immunity, Cellular; Male; Methoxyhydroxyphenylglycol; Middle Aged; Personality Inventory | 1992 |
Fluoxetine and bupropion treatment of bipolar disorder, type II, associated with GAD.
Topics: Anxiety Disorders; Bipolar Disorder; Bupropion; Drug Therapy, Combination; Fluoxetine; Humans; Infant, Newborn; Male; Middle Aged | 1992 |
Tinnitus related to bupropion treatment.
Topics: Antidepressive Agents; Bupropion; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Humans; Middle Aged; Propiophenones; Tinnitus | 1991 |
Treatment choice after one antidepressant fails: a survey of northeastern psychiatrists.
Topics: Antidepressive Agents; Attitude of Health Personnel; Bupropion; Decision Making; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Humans; Lithium; Nortriptyline; Propiophenones; Psychiatry; Triiodothyronine | 1991 |
Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule.
Topics: Animals; Antidepressive Agents; Bupropion; Clozapine; Drug Evaluation, Preclinical; Electroshock; Fluoxetine; Haloperidol; Male; Propiophenones; Rats; Rats, Inbred Strains; Reinforcement Schedule; Trazodone; Zimeldine | 1985 |
Practical approaches to the treatment of social phobia.
Topics: Adrenergic beta-Antagonists; Behavior Therapy; Benzamides; Benzodiazepines; Bupropion; Clonazepam; Comorbidity; Female; Fluoxetine; Humans; Male; Mental Disorders; Moclobemide; Monoamine Oxidase Inhibitors; Phenelzine; Phobic Disorders; Prevalence | 1994 |
Antidepressant-associated mania: a controlled comparison with spontaneous mania.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; Bupropion; Delusions; Diagnosis, Differential; Female; Fluoxetine; Hallucinations; Hospitalization; Humans; Male; Monoamine Oxidase Inhibitors; Psychomotor Agitation; Psychotic Disorders; Retrospective Studies; Severity of Illness Index | 1994 |
Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report.
Topics: Bupropion; Depressive Disorder; Drug Therapy, Combination; Erectile Dysfunction; Fluoxetine; Humans; Libido; Male; Middle Aged; Orgasm | 1994 |
Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.
Topics: Ambulatory Care; Bupropion; Depressive Disorder; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Orgasm; Personal Satisfaction; Psychiatric Status Rating Scales; Severity of Illness Index; Sexual Dysfunctions, Psychological; Treatment Outcome | 1993 |
Panic associated with combining fluoxetine and bupropion.
Topics: Adult; Bupropion; Depressive Disorder; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors | 1996 |
Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.
Topics: 1-Naphthylamine; Adult; Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Bupropion; Dopamine Uptake Inhibitors; Female; Fluoxetine; Humans; Male; Middle Aged; Orgasm; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires | 1997 |
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Anxiety Disorders; Bupropion; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Epilepsy; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Bupropion; Drug Therapy, Combination; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Mood Disorders; Pain Measurement; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome | 1997 |
Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Cyclopropanes; Desipramine; Duloxetine Hydrochloride; Fluoxetine; Male; Milnacipran; Motor Activity; Rats; Rats, Sprague-Dawley; Thiophenes | 1998 |
Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.
Topics: Adult; Algorithms; Amphetamines; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Delayed-Action Preparations; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Fluoxetine; Humans; Methylphenidate; Outcome Assessment, Health Care; Pemoline | 2000 |
Treatment of men with major depression: a comparison of sequential cohorts treated with either cognitive-behavioral therapy or newer generation antidepressants.
Topics: Adult; Antidepressive Agents; Bupropion; Cognitive Behavioral Therapy; Depressive Disorder; Fluoxetine; Humans; Male; Polysomnography; Randomized Controlled Trials as Topic; Treatment Outcome | 2000 |
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
Topics: Antibodies; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Biotransformation; Bupropion; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Isoenzymes; Kinetics; Microsomes, Liver; Oxidoreductases, N-Demethylating; Paroxetine; Piperazines; Sertraline; Triazoles | 2000 |
Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior.
Topics: Animals; Benzazepines; Bupropion; Conditioning, Operant; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Interactions; Fluoxetine; Male; Microinjections; Motor Activity; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Serotonin | 2001 |
Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.
Topics: Animals; Bupropion; Cerebral Cortex; Chromatography, High Pressure Liquid; Dopamine; Dopamine Uptake Inhibitors; Extracellular Space; Fluoxetine; Hematocrit; Limbic System; Male; Microdialysis; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2002 |
Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs.
Topics: Analysis of Variance; Animals; Bupropion; Buspirone; Colon; Corticotropin-Releasing Hormone; Diazepam; Dose-Response Relationship, Drug; Fluoxetine; Gastric Mucosa; Male; Mucins; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stomach Ulcer | 2002 |
Lifestyle drug market booming.
Topics: Anti-Obesity Agents; Bupropion; Drug Industry; Europe; Fluoxetine; Humans; Life Style; Marketing of Health Services; Picolinic Acids; Piperazines; Purines; Sildenafil Citrate; Sulfones; United States | 2002 |
Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Bupropion; Extracellular Space; Fluoxetine; Immobilization; Mice; Mice, Inbred Strains; Neurokinin-1 Receptor Antagonists; Piperidines; Prefrontal Cortex; Swimming; Tetrazoles; Time Factors | 2003 |
Effect of bupropion on sexual dysfunction induced by fluoxetine: a case report of hypersexuality.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Libido; Sexual Dysfunctions, Psychological | 2003 |
QTc prolongation in multiple drug overdose.
Topics: Adult; Bupropion; Drug Overdose; Fluoxetine; Humans; Long QT Syndrome; Male; Piperazines; Psychotic Disorders; Thiazoles; Valproic Acid | 2004 |
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work | 2004 |
Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain.
Topics: Amines; Analgesics; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Constriction; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Male; Morpholines; Motor Activity; Neurotransmitter Uptake Inhibitors; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Reboxetine; Rotarod Performance Test; Spinal Cord Injuries; Vesicular Monoamine Transport Proteins | 2005 |
Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Brain-Derived Neurotrophic Factor; Bupropion; Cerebral Cortex; Desipramine; Drug Tolerance; Fluoxetine; Hippocampus; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; RNA, Messenger; Swimming; Time Factors | 2005 |
Persistent sexual side effects after SSRI discontinuation.
Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonists; Dopamine Uptake Inhibitors; Ergolines; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Piperazines; Plants, Medicinal; Purines; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Sulfones; Testosterone; Time Factors; Treatment Outcome; Vasodilator Agents | 2006 |
Inhibition of dopamine and norepinephrine reuptake produces additive effects on energy balance in lean and obese mice.
Topics: Animals; Behavior, Animal; Body Weight; Bupropion; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Eating; Energy Metabolism; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Motor Activity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Obesity; Piperazines; Time Factors | 2007 |
Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Bupropion; Cells, Cultured; Dose-Response Relationship, Drug; Fluoxetine; Humans; In Situ Hybridization; Lymphocyte Activation; Lymphoma, B-Cell; Male; Middle Aged; Pseudolymphoma; Skin Neoplasms; T-Lymphocytes | 2006 |
Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
Topics: Alanine; Animals; Benztropine; Binding, Competitive; Biological Transport; Bupropion; Chlorocebus aethiops; COS Cells; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Models, Molecular; Mutagenesis, Site-Directed; Norepinephrine Plasma Membrane Transport Proteins; Radioligand Assay; Serine; Transfection; Tritium | 2006 |
Delirium associated with concomitant use of low-dose bupropion sustained release and fluoxetine.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Delirium; Depression; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged | 2006 |
Catecholamine reuptake inhibition causes weight loss by increasing locomotor activity and thermogenesis.
Topics: Animals; Area Under Curve; Behavior, Animal; Bupropion; Catecholamines; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Norepinephrine; Norethandrolone; Piperazines; Telemetry; Thermogenesis; Time Factors; Weight Loss | 2008 |
Antidepressant-like effect of Cordyceps sinensis in the mouse tail suspension test.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Bupropion; Chromatography, Supercritical Fluid; Clorgyline; Cordyceps; Desipramine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Fluoxetine; Head Movements; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Motor Activity; Prazosin; Serotonin Antagonists; Sulpiride; Water | 2007 |
A novel approach for predicting antidepressant-induced sexual dysfunction in rats.
Topics: Animals; Antidepressive Agents; Bupropion; Desipramine; Disease Models, Animal; Dopamine Agonists; Fluoxetine; Long-Term Care; Male; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Vasodilator Agents; Yohimbine | 2008 |
Psychopharmacology of synesthesia; the role of serotonin S2a receptor activation.
Topics: Brain; Bupropion; Color Perception; Fluoxetine; Humans; Male; Melatonin; Models, Biological; Models, Theoretical; Perceptual Disorders; Reading; Receptor, Serotonin, 5-HT2A; Visual Perception | 2008 |
Nicotine exposure during adolescence induces a depression-like state in adulthood.
Topics: Aging; Animals; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Cholinergic Agents; Depression; Emotions; Fluoxetine; Food Preferences; Male; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Reward; Stress, Psychological; Weight Gain | 2009 |
Evaluation of risk factors for elevated tricyclic antidepressant plasma concentrations.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Case-Control Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sex Factors | 2009 |
[Preventing weight gain in smoking cessation: there is no miracle solution].
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Fluoxetine; Humans; Naltrexone; Narcotic Antagonists; Patient Education as Topic; Risk; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Substance Withdrawal Syndrome; Weight Gain | 2009 |
An angry bed partner.
Topics: Anger; Antidepressive Agents, Second-Generation; Bupropion; Coronary Artery Disease; Depressive Disorder; Diagnosis, Differential; Dreams; Electroencephalography; Fluoxetine; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Motor Activity; Polysomnography; Recurrence; REM Sleep Behavior Disorder; Sleep Apnea, Obstructive; Sleep, REM; Spouses | 2009 |
Combining antidepressant medications: a good idea?
Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Fluoxetine; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2010 |
Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion.
Topics: Amitriptyline; Analgesics; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Depression; Disease Models, Animal; Fluoxetine; Hyperalgesia; Ligation; Male; Mice; Motor Activity; Organoselenium Compounds; Pain Measurement; Sciatic Nerve; Sciatica; Swimming; Time Factors | 2010 |
Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows.
Topics: Animals; Antidepressive Agents; Brain; Bupropion; Cyclohexanols; Cyprinidae; Endocrine Disruptors; Female; Fluoxetine; Male; Reproduction; Sertraline; Testis; Venlafaxine Hydrochloride; Vitellogenins; Water Pollutants, Chemical | 2011 |
Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs.
Topics: Animals; Antidepressive Agents; Benzazepines; Biogenic Monoamines; Bupropion; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fenclonine; Fluoxetine; Hypericum; Imipramine; Immobility Response, Tonic; Locomotion; Male; Mice; Mice, Inbred Strains; Phloroglucinol; Plant Extracts; Prazosin; Rats; Rats, Wistar; Receptors, Catecholamine; Sulpiride; Vesicular Monoamine Transport Proteins; Yohimbine | 2012 |
Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task.
Topics: Acetamides; Adrenergic alpha-2 Receptor Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Choice Behavior; Cyclobutanes; Cyclohexanols; Fluoxetine; Hypnotics and Sedatives; Idazoxan; Impulsive Behavior; Male; Norepinephrine; Paroxetine; Rats; Reaction Time; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
The antidepressants fluoxetine and bupropion differentially affect proceptive behavior in the naturally cycling female rat.
Topics: Animals; Antidepressive Agents; Bupropion; Estrous Cycle; Female; Fluoxetine; Humans; Male; Rats; Selective Serotonin Reuptake Inhibitors; Sex Factors; Sexual Behavior, Animal; Yohimbine | 2013 |
Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy?
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Desipramine; Dopamine; Dose-Response Relationship, Drug; Fluoxetine; Imipramine; Male; Morpholines; Norepinephrine; Rats, Sprague-Dawley; Reboxetine; Septal Nuclei; Time Factors | 2014 |
Lack of impairment due to confirmed codeine use prior to a motor vehicle accident: role of pharmacogenomics.
Topics: Accidents, Traffic; Analgesics, Opioid; Bupropion; Codeine; Cytochrome P-450 CYP2D6; Dopamine Uptake Inhibitors; Female; Fluoxetine; Forensic Toxicology; Genetic Carrier Screening; Genotype; Glucuronosyltransferase; Humans; Migraine Disorders; Morphine; Pharmacogenetics; Phenotype; Selective Serotonin Reuptake Inhibitors | 2013 |
Effects of antidepressants on IP-10 production in LPS-activated THP-1 human monocytes.
Topics: Antidepressive Agents; Bupropion; Cell Line; Cell Survival; Chemokine CXCL10; Chromatin Immunoprecipitation; Enzyme-Linked Immunosorbent Assay; Fluoxetine; Gene Expression; Humans; Lipopolysaccharides; Monocytes; p38 Mitogen-Activated Protein Kinases; Signal Transduction | 2014 |
Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice.
Topics: Agmatine; Animals; Antidepressive Agents; Bupropion; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluoxetine; Hindlimb Suspension; Imipramine; Mice; Motor Activity | 2015 |
Antidepressant-like activity of a new piperazine derivative of xanthone in the forced swim test in mice: The involvement of serotonergic system.
Topics: Animals; Antidepressive Agents; Bupropion; Depressive Disorder; Fenclonine; Fluoxetine; Male; Mice; Morpholines; Motor Activity; Piperazines; Postural Balance; Reboxetine; Serotonin; Serotonin Agents; Swimming; Xanthones | 2015 |
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
Topics: Animals; Antidepressive Agents; Benzazepines; Bupropion; Choice Behavior; Desipramine; Dopamine Antagonists; Dose-Response Relationship, Drug; Fluoxetine; Haloperidol; Male; Motivation; Neurotransmitter Uptake Inhibitors; Piperazines; Rats, Sprague-Dawley; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2016 |
Effects of lobeline and reboxetine, fluoxetine, or bupropion combination on depression-like behaviors in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Depression; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Immobility Response, Tonic; Lobeline; Male; Mice; Morpholines; Reboxetine | 2015 |
Failure to detect the action of antidepressants in the forced swim test in Swiss mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Butyric Acid; Desipramine; Fluoxetine; Immobility Response, Tonic; Male; Mice; Motor Activity | 2018 |
Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose.
Topics: Benzodiazepines; Bupropion; Cyproheptadine; Dopamine Uptake Inhibitors; Drug Overdose; Fluoxetine; Humans; Male; Olanzapine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Serotonin Syndrome; Time Factors; Trazodone; Young Adult | 2018 |
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride | 2018 |
Molecular basis of atypicality of bupropion inferred from its receptor engagement in nervous system tissues.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Depression; Fluoxetine; Ganglia, Spinal; Humans; Norepinephrine; Pineal Gland; Receptors, Nicotinic; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin; Smoking Cessation; Venlafaxine Hydrochloride | 2018 |
Preliminary evidence of an association between increased cortical inhibition and reduced suicidal ideation in adolescents treated for major depression.
Topics: Adolescent; Adolescent Behavior; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Motor Cortex; Neural Inhibition; Suicidal Ideation; Suicide Prevention; Transcranial Magnetic Stimulation | 2019 |
Antidepressant Prescription Patterns in Bipolar Disorder: a Nationwide, Register-based Study in Korea.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Bupropion; Citalopram; Female; Fluoxetine; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Prevalence; Registries; Republic of Korea | 2018 |
Effects of monoamine uptake inhibitors on pain-related depression of nesting in mice.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Bupropion; Citalopram; Conditioning, Operant; Dopamine Uptake Inhibitors; Fluoxetine; Ketoprofen; Lactic Acid; Male; Mice; Mice, Inbred ICR; Milnacipran; Nesting Behavior; Pain; Receptors, Opioid, kappa; Self Stimulation | 2019 |
Bupropion, a possible antidepressant without negative effects on alcohol relapse.
Topics: Alcohol Drinking; Alcoholism; Animals; Antidepressive Agents, Second-Generation; Bupropion; Dopamine Uptake Inhibitors; Endocannabinoids; Fluoxetine; Male; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Glutamate; Recurrence; RNA, Messenger; Selective Serotonin Reuptake Inhibitors | 2019 |
Antidepressants with different mechanisms of action show different chronopharmacological profiles in the tail suspension test in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Circadian Rhythm; Depression; Dopamine; Fluoxetine; Imipramine; Male; Mice; Mice, Inbred C57BL; Movement; Norepinephrine; Time Factors; Venlafaxine Hydrochloride | 2019 |
Dopamine and norepinephrine transporter inhibition for long-term fear memory enhancement.
Topics: Animals; Atomoxetine Hydrochloride; Behavior, Animal; Bupropion; Central Nervous System Stimulants; Conditioning, Classical; Dopamine Plasma Membrane Transport Proteins; Drug Therapy, Combination; Fear; Female; Fluoxetine; Male; Memory, Long-Term; Mice; Mice, Inbred C57BL; Neurotransmitter Uptake Inhibitors; Nootropic Agents; Norepinephrine Plasma Membrane Transport Proteins | 2020 |
Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Brain; Bupropion; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Imipramine; Mice; Molecular Docking Simulation; Monoamine Oxidase; Norepinephrine; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-2; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA-A; Receptors, Serotonin; Receptors, Serotonin, 5-HT2; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tyramine | 2020 |
Ketamine treatment protects against oxidative damage and the immunological response induced by electroconvulsive therapy.
Topics: Animals; Antidepressive Agents; Bupropion; Combined Modality Therapy; Depressive Disorder, Major; Electroconvulsive Therapy; Fluoxetine; Ketamine; Male; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar | 2021 |
The role of uptake and degradation in the regulation of peripheral serotonin dynamics in Gulf toadfish, Opsanus beta.
Topics: Animals; Batrachoidiformes; Biological Transport; Bupropion; Clorgyline; Fluoxetine; Gene Expression Regulation; Homeostasis; Ion Transport; Quinolines; Serotonin; Serotonin Plasma Membrane Transport Proteins; Temperature | 2021 |
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study.
Topics: Antidepressive Agents; Bupropion; Citalopram; Duloxetine Hydrochloride; Escitalopram; Female; Fluoxetine; Humans; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2021 |
Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway.
Topics: Antidepressive Agents; Atenolol; Bisoprolol; Bupropion; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Drug Prescriptions; Fluoxetine; Humans; Metoprolol; Paroxetine; Retrospective Studies | 2022 |
Effects of the dopamine depleting agent tetrabenazine in tests evaluating different components of depressive-like behavior in mice: sex-dependent response to antidepressant drugs with SERT and DAT blocker profiles.
Topics: Animals; Antidepressive Agents; Bupropion; Dopamine; Female; Fluoxetine; Humans; Male; Mice; Sucrose; Tetrabenazine | 2023 |
Simultaneous separation and determination of several chiral antidepressants and their enantiomers in wastewater by online heart-cutting two-dimensional liquid chromatography.
Topics: Antidepressive Agents; Bupropion; Chromatography, High Pressure Liquid; Fluoxetine; Mirtazapine; Stereoisomerism; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2023 |
Environmental enrichment affects behavioral and pharmacological response to antidepressants in CF1 mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Bupropion; Female; Fluoxetine; Hippocampus; Male; Mice; Pregnancy; Swimming | 2023 |